{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:53:54Z","timestamp":1782888834339,"version":"3.54.5"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"College of Mental Health Pharmacy","award":["PRUK_CMHP-2019-2-RG"],"award-info":[{"award-number":["PRUK_CMHP-2019-2-RG"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Misuse of over-the-counter (OTC) and prescription-only medicines (POMs) is increasingly recognised as a public health and medicine-safety concern. Although specialist substance misuse services (SMS) increasingly support people affected by OTC\/POM misuse, little is known about how SMS staff perceive the characteristics, challenges, and treatment needs of this population. This study explored the experiences of SMS staff to address this evidence gap and inform pharmacy practice and service development. Confidential semi-structured interviews were conducted with staff across five community adult English SMS. Audio recordings were transcribed verbatim and analysed thematically using NVivo\u00ae. Twenty interviews with varied professionals achieved data saturation. Three overarching themes emerged: (1) characteristics of OTC\/POM misuse; (2) staff-perceived patterns among people who misuse OTC\/POM; and (3) negative experiences and concerns. Dependence on orally administered opioids (particularly codeine-containing products), benzodiazepines and gabapentinoids predominated. Polypharmacy including illicit substance use was also reported. Withdrawal symptoms frequently perpetuated misuse, and abrupt supply cessation created additional risks. Routine enquiry about OTC\/POM misuse and provision of tailored harm-reduction interventions are essential. The findings suggest that pharmacists may have an important role in early identification of problematic OTC\/POM use, harm-reduction interventions, medicine review and facilitating referral into appropriate treatment pathways. Further research should examine whether dedicated OTC\/POM pathways are required and explore differences in demographic and treatment needs across medicine types.<\/jats:p>","DOI":"10.3390\/pharmacy14040094","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:06:34Z","timestamp":1782875194000},"page":"94","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cThe Most High-Risk People Are Given the Most High-Risk Drugs in the Most High-Risk Way\u201d: Experiences of Treating Problematic Over-the-Counter and Prescription-Only Medication Use in Substance Misuse Services"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-7936","authenticated-orcid":false,"given":"Rosalind","family":"Gittins","sequence":"first","affiliation":[{"name":"Aston Pharmacy School, Aston University, Birmingham B4 7ET, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Vaziri","sequence":"additional","affiliation":[{"name":"Waythrough, Inspiration House, Unit 22, Bowburn North Industrial Estate, Durham DH6 5PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4152-9704","authenticated-orcid":false,"given":"Ian","family":"Maidment","sequence":"additional","affiliation":[{"name":"Aston Pharmacy School, Aston University, Birmingham B4 7ET, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","unstructured":"Scottish Drug Forum (SDF) (2026, March 12). Moving Beyond \u2018People-First\u2019 Language. Available online: https:\/\/sdf.org.uk\/wp-content\/uploads\/2024\/05\/Moving-Beyond-People-First-Language-A-glossary-of-contested-terms-in-substance-use.pdf."},{"key":"ref_2","first-page":"11782218221135875","article-title":"Surveying Over the Counter and Prescription Only Medication Misuse in Treatment Services During COVID-19","volume":"16","author":"Gittins","year":"2022","journal-title":"Subst. Abus."},{"key":"ref_3","unstructured":"Office for Health Improvement and Disparities (OHID) (2026, March 12). Adult Substance Misuse Treatment Statistics 2022 to 2023: Report, Available online: https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2022-to-2023\/adult-substance-misuse-treatment-statistics-2022-to-2023-report."},{"key":"ref_4","unstructured":"Public Health England (PHE) (2026, March 12). National Drug Treatment Monitoring System (NDTMS): Adult Drug and Alcohol Treatment Business Definitions. Core Dataset P V14.3, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/897149\/NDTMS_adult_drug_and_alcohol_treatment_business_definitions_V14.3.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"i5725","DOI":"10.1136\/bmj.i5725","article-title":"BMA calls for national prescription drug helpline","volume":"355","author":"Kmietowicz","year":"2016","journal-title":"BMJ"},{"key":"ref_6","unstructured":"Public Health England (PHE) (2026, March 12). New Psychoactive Substances: A Toolkit for Substance Misuse Commissioners, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/669429\/nps-a-toolkit-for-substance-misuse-commissioners.pdf."},{"key":"ref_7","unstructured":"National Institute for Health and Social Care Excellence (NICE) (2026, March 12). Medicines Associated with Dependence or Withdrawal Symptoms: Safe Prescribing and Withdrawal Management for Adults, Available online: https:\/\/www.nice.org.uk\/guidance\/ng215."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/dar.13081","article-title":"Experiences of over-the-counter codeine misusers and accounts of recovery: A qualitative study in Tasmania, Australia","volume":"39","author":"Kirschbaum","year":"2020","journal-title":"Drug Alcohol. Rev."},{"key":"ref_9","unstructured":"United Nations Office on Drugs and Crime (UNODC) (2026, March 12). The Non-Medical Use of Prescription Drugs: Policy Direction Issues. Available online: https:\/\/www.unodc.org\/documents\/drug-prevention-and-treatment\/nonmedical-use-prescription-drugs.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20503245231215407","DOI":"10.1177\/20503245231215407","article-title":"\u2018It\u2019s a horrible situation for everyone\u2019: The impact of over the counter and prescription medication misuse on friends and family","volume":"9","author":"Gittins","year":"2023","journal-title":"Drug Sci. Policy Law"},{"key":"ref_11","unstructured":"Office for National Statistics (ONS) (2026, March 12). Deaths Related to Drug Poisoning in England and Wales: 2022 Registrations, Available online: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2022registrations."},{"key":"ref_12","unstructured":"Department of Health and Social Care (DHSC) (2026, March 12). From Harm to Hope: A 10-Year Drugs Plan to Cut Crime and Save Lives, Available online: https:\/\/www.gov.uk\/government\/publications\/from-harm-to-hope-a-10-year-drugs-plan-to-cut-crime-and-save-lives\/from-harm-to-hope-a-10-year-drugs-plan-to-cut-crime-and-save-lives."},{"key":"ref_13","unstructured":"Public Health England (PHE) (2026, March 12). Dependence and Withdrawal Associated with Some Prescribed Medicines: An Evidence Review, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/940255\/PHE_PMR_report_Dec2020.pdf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7517-7-21","article-title":"Innocent parties or devious drug users: The views of primary healthcare practitioners with respect to those who misuse prescription drugs","volume":"7","author":"Butler","year":"2010","journal-title":"Harm Reduct. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.07.011","article-title":"Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers","volume":"105","author":"Buttram","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13722-019-0170-4","article-title":"Staff perceptions of prescription and over-the-counter drug dependence services in England: A qualitative study","volume":"14","author":"Coombes","year":"2019","journal-title":"Addict. Sci. Clin. Pract."},{"key":"ref_17","first-page":"11782218221111833","article-title":"Misuse of Over the Counter and Prescription Only Medication by Adults Accessing Specialist Treatment Services in the UK: A Narrative Synthesis","volume":"16","author":"Gittins","year":"2022","journal-title":"Subst. Abus."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/00220426221080204","article-title":"Improving the Recruitment and Retention of Counselors in Rural Substance Use Disorder Treatment Programs","volume":"52","author":"Murphy","year":"2022","journal-title":"J. Drug Issues"},{"key":"ref_19","unstructured":"Royal College of Psychiatry (RCPsych) (2026, March 12). Training in Addiction Psychiatry: Current Status and Future Prospects. Available online: https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/members\/faculties\/addictions-psychiatry\/training-in-addiction-psychiatry---current-status-and-future-prospects-(web).pdf?sfvrsn=14de2911_2."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/fampra\/20.2.120","article-title":"A qualitative study of GPs\u2019 attitudes to drug misusers and drug misuse services in primary care","volume":"20","author":"McKeown","year":"2003","journal-title":"Fam. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14659890600774789","article-title":"What\u2019s the problem? Why do some pharmacists provide services to drug users and others won\u2019t?","volume":"12","author":"Roberts","year":"2007","journal-title":"J. Subst. Use"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How Many Interviews Are Enough? An Experiment with Data Saturation and Variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"ref_23","unstructured":"Gibbs, G. (2002). Qualitative Data Analysis: Explorations with NVivo, Open University Press."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"key":"ref_25","unstructured":"Green, J., and Thorogood, N. (2014). Qualitative Methods for Health Research, Sage Publications Ltd.. [3rd ed.]."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2215-0366(19)30331-1","article-title":"Medicines associated with dependence or withdrawal: A mixed-methods public health review and national database study in England","volume":"6","author":"Marsden","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref_28","unstructured":"Canadian Centre on Substance Use and Addiction (CCENDU) (2026, March 12). CCENDU Bulletin: Risks and Harms Associated with the Nonmedical Use of Benzodiazepines in the Unregulated Drug Supply in Canada. Available online: https:\/\/www.ccsa.ca\/risks-and-harms-associated-nonmedical-use-benzodiazepines-unregulated-drug-supply-canada-ccendu."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ADM.0000000000000511","article-title":"Psychotropics in Your Medicine Cabinet: A Case Study of Dimenhydrinate Use","volume":"13","author":"Wen","year":"2019","journal-title":"J. Addict. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103298","DOI":"10.1016\/j.drugpo.2021.103298","article-title":"A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage","volume":"96","author":"Burton","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/dar.13554","article-title":"Patient, family members and community pharmacists\u2019 views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study","volume":"42","author":"Mercer","year":"2023","journal-title":"Drug Alcohol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13011-018-0174-1","article-title":"Pharmacological neuroenhancement and the ability to recover from stress\u2014A representative cross-sectional survey among the German population","volume":"13","author":"Bagusat","year":"2018","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"ref_33","first-page":"1","article-title":"Misuse of prescription and over-the-counter drugs to obtain illicit highs: How pharmacists can prevent abuse","volume":"305","author":"Chiappini","year":"2020","journal-title":"Pharm. J."},{"key":"ref_34","unstructured":"Lipari, R.N., Williams, M., and Van Horn, S.L. (2026, March 12). Why Do Adults Misuse Prescription Drugs?, The CBHSQ Report, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK458284\/."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chhatre, S., Cook, R., Mallik, E., and Jayadevappa, R. (2017). Trends in substance use admissions among older adults. BMC Health Serv. Res., 17.","DOI":"10.1186\/s12913-017-2538-z"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10550887.2012.665729","article-title":"Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment","volume":"31","author":"Tkacz","year":"2012","journal-title":"J. Addict. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fingleton, N., Duncan, E., Watson, M., and Matheson, C. (2019). Specialist Clinicians\u2019 Management of Dependence on Non-Prescription Medicines and Barriers to Treatment Provision: An Exploratory Mixed Methods Study Using Behavioural Theory. Pharmacy, 7.","DOI":"10.3390\/pharmacy7010025"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106784","DOI":"10.1016\/j.addbeh.2020.106784","article-title":"Stigma and policy preference toward individuals who transition from prescription opioids to heroin","volume":"115","author":"Goodyear","year":"2021","journal-title":"Addict. Behav."},{"key":"ref_39","unstructured":"National Health Service England (NHSE) (2026, March 12). Optimising Personalised Care for Adults Prescribed Medicines Associated with Dependence or Withdrawal Symptoms: Framework for Action for Integrated Care Boards (ICBs) and Primary Care, Available online: https:\/\/www.england.nhs.uk\/long-read\/optimising-personalised-care-for-adults-prescribed-medicines-associated-with-dependence-or-withdrawal-symptoms\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1526-4637.2009.00603.x","article-title":"Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment","volume":"10","author":"Inciardi","year":"2009","journal-title":"Pain Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3122\/jabfm.2008.01.070071","article-title":"Abuse of prescription and over-the-counter medications","volume":"21","author":"Lessenger","year":"2008","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_42","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) (2026, March 12). Codeine Linctus to be Reclassified to a Prescription-Only Medicine Because of Risk of Abuse and Addiction, Available online: https:\/\/www.gov.uk\/government\/news\/codeine-linctus-to-be-reclassified-to-a-prescription-only-medicine-because-of-risk-of-abuse-and-addiction#:~:text=As%20a%20result%2C%20and%20taking,can%20be%20a%20gradual%20process."},{"key":"ref_43","unstructured":"O\u2019Connor, R. (2026, March 12). Involving Recovering Alcohol and Drug Users in the Delivery and Design of Treatment and Recovery. UK Health Security Agency, Available online: https:\/\/ukhsa.blog.gov.uk\/2015\/09\/07\/involving-recovering-alcohol-and-drug-users-in-the-delivery-and-design-of-treatment-and-recovery\/."},{"key":"ref_44","first-page":"238","article-title":"Doktorlar arasinda madde k\u00f6t\u00fcye kullanimi bir sorun mu? [Is substance abuse among physicians a problem?]","volume":"13","author":"Akvardar","year":"2002","journal-title":"Turk. Psikiyatr. Derg."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/4\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:17:39Z","timestamp":1782883059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/4\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmacy14040094"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy14040094","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}